In murine tumor models where HGF from hepatic stellate cells (HSC)-derived CAFs or MET from tumor cell sources was deleted using Lrat-Cre-transgenic mice, a significant reduction in tumor invasiveness and size was observed [40]. The gene discussed is MET; the disease is neoplasm.